Rodrigo P. Mello

Intravenous arketamine for treatment-resistant depression: open-label pilot study

Gustavo C. Leal, Igor D. Bandeira, Fernanda S. Correia‐Melo et al. · European Archives of Psychiatry and Clinical Neuroscience · 2020 · 249 citations · Full text

Psychiatry, Intravenous Arketamine, Psychotropic Medication +6

Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study

Fernanda S. Correia‐Melo, Gustavo C. Leal, Flávia Vieira et al. · Journal of Affective Disorders · 2019 · 171 citations

Adjunctive Therapy, Psychiatry, Psychotropic Medication +7

Comparative study of esketamine and racemic ketamine in treatment-resistant depression

Fernanda S. Correia‐Melo, Gustavo C. Leal, Michelle S. Carvalho et al. · Medicine · 2018 · 57 citations · Full text

Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study

Gustavo C. Leal, Breno Souza‐Marques, Rodrigo P. Mello et al. · Journal of Affective Disorders · 2023 · 49 citations

Adjunctive Therapy, Psychiatry, Mood Symptom +13

Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study

Lucas Araújo-de-Freitas, Cassio Santos‐Lima, Euclides Mendonça-Filho et al. · Psychiatry Research · 2021 · 37 citations

Neuropsychology, Psychiatry, Mood Symptom +13